Comment
Author: Admin | 2025-04-28
Summary: Drug interactions are reported among people who take Tamiflu (oseltamivir phosphate) and Methylprednisolone (methylprednisolone). Common drug interactions include musculoskeletal stiffness among females and chronic kidney disease among males. The phase IV clinical study analyzes what interactions people have when they take Tamiflu and Methylprednisolone, and groups them by gender, age and more. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly. With medical big data and AI/ML algorithms, eHealthMe is able to run millions of data-driven phase IV clinical trials continuously. In comparison, only 2,000 traditional phase IV trials are run each year globally. Our original studies have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. On Dec, 22, 2024 100 people who take Tamiflu and Methylprednisolone together, and have interactions are studied. What is Tamiflu? Tamiflu has active ingredients of oseltamivir phosphate. It is often used in the flu. eHealthMe is studying from 22,210 Tamiflu users for the drug's side effects, drug interactions, effectiveness and more. Check Tamiflu in the real world. What is Methylprednisolone? Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,636 Methylprednisolone users for the drug's side effects, drug interactions, effectiveness and more. Check Methylprednisolone in the real world. Number of Tamiflu and Methylprednisolone reports submitted per year: What are the common drug interactions of Tamiflu and Methylprednisolone, by gender? *: female: Musculoskeletal stiffness Paraesthesia Weight
Add Comment